Erik Fleming, a licensed addiction counselor based in New York City, has been sentenced to two years in prison after admitting to supplying actor Matthew Perry with ketamine, including the fatal dose that led to the star’s death. Fleming’s sentencing marks a sobering chapter in the ongoing conversation about substance abuse and the responsibilities of medical professionals in the city’s struggling addiction treatment landscape.

Perry, beloved for his role on the iconic New York-set series “Friends,” died after an overdose involving ketamine, a powerful anesthetic sometimes used off-label in mental health treatment but fraught with risk when misused. Fleming confessed to providing 51 vials of the drug to Perry, a breach of both legal and ethical boundaries that has brought renewed scrutiny to the regulation of controlled substances in addiction therapy.

New York City has long battled the opioid epidemic and rising overdose deaths, with ketamine emerging in certain circles as a controversial element in treatment protocols. The case underscores the challenges faced by counselors and medical providers operating in a complex and often under-resourced system. Advocates argue that stricter oversight and enhanced support for both patients and practitioners are critical to preventing similar tragedies.

While Fleming’s sentence offers a measure of accountability, it also highlights the urgent need for comprehensive reform in addiction care across the city. Perry’s death has reignited public debate about the fine line between therapeutic use and abuse of substances like ketamine, especially in a city that continues to grapple with the human toll of addiction amid ongoing public health crises.

As New York City strives to improve its approach to addiction treatment, this case serves as a poignant reminder of the stakes involved when vulnerable individuals seek help. The legacy of Perry’s tragic passing is now intertwined with a call for greater vigilance and compassion in the practices that aim to save lives.

Editorial Transparency. A first draft of this story was produced with AI-assisted writing tools, then reviewed for accuracy and tone by the named editor before publication. More on our process: Editorial Policy.

Subscribe to our newsletter

Weekly stories, neighborhood notes, and what's opening this week.